Brief: Abbott India Signs A Non-Exclusive Patent License Agreement With Takeda Pharmaceuticals Co
19/09/2024 14:47
Sept 19 (Reuters) - Abbott India Ltd ABOT.NS :
* SIGNS A NON-EXCLUSIVE PATENT LICENSE AGREEMENT WITH TAKEDA
PHARMACEUTICALS CO
* AGREEMENT TO MARKET AND DISTRIBUTE "VONOPRAZAN" IN INDIA
Source text for Eikon: ID:nBSE79bwMK
Further company coverage: ABOT.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Abbott India
See all newsJP Morgan downgrades Abbott India to 'neutral' citing growth headwinds
Brief: Abbott India Partners With Novo Nordisk India To Launch Extensior
Brief: Abbott India Dec-Quarter Profit 3.76 Billion Rupees
Brief: Abbott India Receives Tax Penalty Of 24 Million Rupees
Brief: Central Government Approves Kartik Rajendran As MD of Abbott India